Literature DB >> 9920845

Shaping the repertoire of cytotoxic T-lymphocyte responses: explanation for the immunodominance effect whereby cytotoxic T lymphocytes specific for immunodominant antigens prevent recognition of nondominant antigens.

S Pion1, G J Christianson, P Fontaine, D C Roopenian, C Perreault.   

Abstract

The immunodominance effect, whereby the presence of immunodominant epitopes prevents recognition of nondominant determinants presented on the same antigen-presenting cell (APC) considerably restricts the repertoire of cytotoxic T lymphocyte (CTL) responses. To elucidate the molecular basis of the immunodominance effect, we compared the interactions of a dominant (B6(dom1)) and a nondominant epitope (H-Y) with their restricting class I molecule (H2-Db), and their ability to trigger cognate CTLs. We found that B6(dom1)/Db complexes behaved as optimal T-cell receptor (TCR) ligands and triggered a more rapid in vivo expansion of cognate CTLs than H-Y/Db complexes. The superiority of the dominant epitope was explained by its high cell surface density (1,012 copies/cell for B6(dom1) v 10 copies/cell for H-Y) and its optimal affinity for cognate TCRs. Based on these results, we conclude that dominant class I-associated epitopes are those that have optimal ability to trigger TCR signals in CTLs. We propose that the rapid expansion of CTLs specific for dominant antigens should enable them to compete more successfully than other CTLs for occupancy of the APC surface.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 9920845

Source DB:  PubMed          Journal:  Blood        ISSN: 0006-4971            Impact factor:   22.113


  8 in total

Review 1.  RNA-transfected dendritic cells in cancer immunotherapy.

Authors:  D A Mitchell; S K Nair
Journal:  J Clin Invest       Date:  2000-11       Impact factor: 14.808

2.  Tumor-derived autophagosome vaccine: induction of cross-protective immune responses against short-lived proteins through a p62-dependent mechanism.

Authors:  Christopher G Twitty; Shawn M Jensen; Hong-Ming Hu; Bernard A Fox
Journal:  Clin Cancer Res       Date:  2011-08-02       Impact factor: 12.531

Review 3.  Increasing the efficacy of tumor cell vaccines by enhancing cross priming.

Authors:  Brian M Andersen; John R Ohlfest
Journal:  Cancer Lett       Date:  2012-07-16       Impact factor: 8.679

4.  Direct presentation regulates the magnitude of the CD8+ T cell response to cell-associated antigen through prolonged T cell proliferation.

Authors:  Angela M Tatum; Alan M Watson; Todd D Schell
Journal:  J Immunol       Date:  2010-07-26       Impact factor: 5.422

5.  Portable flanking sequences modulate CTL epitope processing.

Authors:  Sylvie Le Gall; Pamela Stamegna; Bruce D Walker
Journal:  J Clin Invest       Date:  2007-11       Impact factor: 14.808

6.  Deletion of naïve T cells recognizing the minor histocompatibility antigen HY with toxin-coupled peptide-MHC class I tetramers inhibits cognate CTL responses and alters immunodominance.

Authors:  Sabrina M Hess; Ellen F Young; Keith R Miller; Benjamin G Vincent; Adam S Buntzman; Edward J Collins; Jeffrey A Frelinger; Paul R Hess
Journal:  Transpl Immunol       Date:  2013-10-23       Impact factor: 1.708

7.  Differential outcome of tolerance induction in naive versus activated Theiler's virus epitope-specific CD8+ cytotoxic T cells.

Authors:  Meghann Teague Getts; Byung S Kim; Stephen D Miller
Journal:  J Virol       Date:  2007-04-11       Impact factor: 5.103

8.  Broadening of the T-cell repertoire to HIV-1 Gag p24 by vaccination of HLA-A2/DR transgenic mice with overlapping peptides in the CAF05 adjuvant.

Authors:  Karen S Korsholm; Ingrid Karlsson; Sheila T Tang; Lea Brandt; Else Marie Agger; Claus Aagaard; Peter Andersen; Anders Fomsgaard
Journal:  PLoS One       Date:  2013-05-17       Impact factor: 3.240

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.